How long should Eliquis (apixaban) be held in a patient with normal renal function prior to an epidural injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long to Hold Eliquis for Epidural Injection

For patients with normal renal function undergoing epidural injection, hold Eliquis (apixaban) for at least 48 hours (4 doses) prior to the procedure, and extend this to 72-120 hours (up to 5 days) for neuraxial procedures due to their very high hemorrhagic risk. 1

Risk Classification

Epidural injections and neuraxial anesthesia/puncture are classified as very high hemorrhagic risk procedures because:

  • Spinal/epidural bleeding can cause permanent neurological damage from spinal cord compression 2
  • Surgical hemostasis cannot be performed safely in the confined space of the spinal canal 1
  • These procedures require complete hemostasis with no margin for error 2

Specific Hold Duration for Normal Renal Function (CrCl >50 mL/min)

The French Working Group on Perioperative Hemostasis strongly recommends holding apixaban for up to 5 days before neuraxial anesthesia/puncture in patients without renal failure. 1

For patients with normal renal function:

  • Minimum hold: 48 hours (standard for high-risk procedures) 2, 3
  • Recommended for neuraxial procedures: 72-120 hours (3-5 days) due to catastrophic consequences of epidural hematoma 1
  • The last dose should be taken 3 days before the procedure when CrCl >30 mL/min 1

Adjustments for Renal Impairment

If creatinine clearance is reduced, extend the hold duration:

  • CrCl 30-50 mL/min: Hold for 72-96 hours 2
  • CrCl <30 mL/min: Consider 96-120 hours (4-5 days) and consult hematology 1, 2
  • Apixaban has 27% renal elimination, making renal function critical to clearance 4

Additional Risk Factors Requiring Extended Hold

Extend the interruption period to the full 5 days if the patient has: 1

  • Age ≥80 years 5
  • Concomitant P-glycoprotein inhibitors (e.g., verapamil, amiodarone)
  • Concomitant CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)
  • Body weight ≤60 kg
  • Any factor suggesting drug accumulation

Critical Safety Warnings

The French Working Group strongly recommends NOT performing spinal or epidural anesthesia in patients with possible residual apixaban concentration due to insufficient discontinuation time. 1

The FDA label explicitly states:

  • "Optimal timing between the administration of apixaban and neuraxial procedures is not known" 3
  • Risk factors for epidural/spinal hematoma include indwelling catheters, concomitant NSAIDs/antiplatelet agents, and history of traumatic puncture 3

Bridging Anticoagulation

Do NOT use bridging anticoagulation with heparin or LMWH during the interruption period. 1

  • Bridging significantly increases bleeding risk without reducing thrombotic events 2, 5
  • The brief interruption period does not warrant bridging except in extremely high thrombotic risk patients 1

Resumption After Procedure

Resume apixaban at least 24-48 hours after the epidural procedure once adequate hemostasis is established. 2, 3

  • For neuraxial procedures, wait 24-48 hours minimum 2
  • Restart at the patient's usual maintenance dose 5
  • If ongoing bleeding or surgical contraindication exists, delay resumption further 1

Common Pitfalls to Avoid

  • Failing to obtain recent creatinine clearance before determining hold duration can lead to inadequate drug clearance 6
  • Not accounting for the 48-hour period correctly: This means 4 full doses are skipped (2 full days of twice-daily dosing), not just holding the morning dose 5
  • Performing the procedure too early in elderly patients or those on interacting medications without extending the hold period 1
  • Using bridging anticoagulation unnecessarily, which increases bleeding risk 1, 2

Practical Algorithm

  1. Verify renal function using Cockcroft-Gault formula 1
  2. Check for drug interactions (P-gp or CYP3A4 inhibitors) 1
  3. Determine hold duration:
    • Normal renal function + no risk factors: 72 hours minimum (3 days)
    • Normal renal function + age >80 or drug interactions: 96-120 hours (4-5 days)
    • CrCl 30-50: 72-96 hours
    • CrCl <30: 96-120 hours + hematology consultation
  4. Do not bridge with heparin 1
  5. Resume 24-48 hours post-procedure once hemostasis confirmed 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Apixaban for Ascitic Tapping and Lumbar Puncture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Eliquis Management for Vasectomy Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Perioperative Management of Xarelto (Rivaroxaban)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.